Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...

Shares of Becton Dickinson & Co. BDX slipped 1.60% to $225.85 Wednesday, on what proved to be an all-around rough trading ...

Scott Bertram, a director at Becton Dickinson & Co. (NYSE:BDX), recently sold 700 shares of the company's common stock, according to a recent filing with the Securities and Exchange Commission. The ...

American medical technology (MedTech) company Becton Dickinson (BDX) plans to split from its bioscience and diagnostic ...

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Barclays analyst Matt Miksic maintained a Buy rating on Becton Dickinson (BDX – Research Report) today and set a price target of $278.00. The ...

Becton, Dickinson and Company is rated a hold due ... Although this analysis doesn’t always equate to further stock price hikes, as you can see from its brief pass of the 200-day in October ...

MMSI currently has a PEG ratio of 2.28. Another notable valuation metric for BDX is its P/B ratio of 2.64. Investors use the P/B ratio to look at a stock's market value versus its book value ...